Novel systemic therapy against malignant pleural mesothelioma.
about
Amatuximab and novel agents targeting mesothelin for solid tumors.Patterns of care and survival among patients with malignant mesothelioma in the United States.Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.Malignant pleural mesothelioma: some progress, but still a long way from cure.
P2860
Novel systemic therapy against malignant pleural mesothelioma.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Novel systemic therapy against malignant pleural mesothelioma.
@ast
Novel systemic therapy against malignant pleural mesothelioma.
@en
type
label
Novel systemic therapy against malignant pleural mesothelioma.
@ast
Novel systemic therapy against malignant pleural mesothelioma.
@en
prefLabel
Novel systemic therapy against malignant pleural mesothelioma.
@ast
Novel systemic therapy against malignant pleural mesothelioma.
@en
P2860
P356
P1476
Novel systemic therapy against malignant pleural mesothelioma.
@en
P2093
Joel W Neal
Michael R Mancuso
P2860
P304
P356
10.21037/TLCR.2017.06.01
P577
2017-06-01T00:00:00Z